Enterprise Value
92.33M
Cash
309.9M
Avg Qtr Burn
-16.72M
Short % of Float
19.97%
Insider Ownership
0.91%
Institutional Own.
-
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EDG-5506 Details Becker Muscular Dystrophy, Duchenne muscular dystrophy | Phase 2 Data readout | |
EDG-5506 Details Becker Muscular Dystrophy | Phase 2 Data readout | |
EDG-5506 Details Rare diseases, Duchenne muscular dystrophy | Phase 2 Data readout | |
EDG-5506 Details Rare diseases, Limb-Girdle Muscular Dystrophy, McArdle disease | Phase 2 Data readout | |
EDG-5506 Details Duchenne muscular dystrophy, Rare diseases | Phase 2 Initiation | |
EDG-7500 Details Heart disease, Hypertrophic cardiomyopathies | Phase 1 Data readout |